Why Medpace Holdings Is Skyrocketing 13.5% Higher Today
After reporting second-quarter financials that beat industry watchers' estimates, Medpace Holdings (NASDAQ: MEDP) shares are soaring 13.5% higher at 11:55 a.m. EDT on Tuesday.
Investors were concerned revenue and profitability would be crimped by reduced clinical trial activity because of COVID-19 precautions. Safety measures limiting risk to clinical trial participants and workers did weigh down the healthcare company's second-quarter performance, but not nearly as badly as feared.
IMAGE SOURCE: GETTY IMAGES.
Source Fool.com
